The Belgian group’s “one-two punch” strategy “CDC7 inhibitor-induced senescence” + “mTOR blocker-triggered apoptosis” effectively eliminated hepatocellular carcinoma cells with improved patient tolerance compared to conventional cytotoxic therapies [23]. The gene discussed is CDC7; the disease is hepatocellular carcinoma.